← Eichor
Study identifier: NCT06581692 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Non-invasive Monitoring of Miscarriage

Condition: Miscarriage in First Trimester  ·  Sponsor: Chinese University of Hong Kong

PhaseN/A
Planned participants150
Who can joinAll sexes, 18 Years to 45 Years
Healthy volunteersNo

About this study

cfDNA is extremely useful to ascertain chromosomal causes of miscarriages at the point of miscarriage diagnosis by a simple blood test. This study aims to determine the level of cell-free DNA (cfDNA) in early pregnancy and compare the results with those of product of conception (POC) testing, in concordance with standard karyotyping.

This description comes directly from the study's public registry record.

Talk to the study team

PUI WAH JACQUELINE CHUNG  ·  +852 35051764  ·  jacquelinechung@cuhk.edu.hk

Yee Lee Elaine NG  ·  +852 35052745  ·  elaineng@cuhk.edu.hk

Always discuss trial participation with your own doctor first.

Locations (1)

Prince of Wales HospitalHong Kong, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06581692